As the radiologic evaluation of soft tissue masses has changed dramatically with the advent of MR imaging, the effect of MR imaging is even more striking in the assessment of patients after treatment. In cases of local tumor recurrence, MR imaging has become the standard of care. Using a few basic principles, even small local recurrences can be detected accurately, and recurrence can be distinguished from postoperative or post-treatment change. This review presents a fundamental approach to the evaluation of patients, following treatment for soft tissue tumors and highlighting MR imaging.
aMayo Clinic College of Medicine, 200 First Street, SW, Rochester, MN 55905, USA
bDepartment of Radiology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224-3899, USA
cDepartment of Radiologic Pathology, Armed Forces Institute of Pathology, 6825 16th Street, NW, Building 54, Room 133A, Washington, DC 20306-6000, USA
dDepartment of Radiology and Nuclear Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814-4799, USA
eDepartment of Radiology, Walter Reed Army Medical Center, 6900 Georgia Avenue, NW, Building 2, Washington, DC 20307-5001, USA
Corresponding author. Department of Radiology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224-4301
The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.